Financial Gravity Companies’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Financial Gravity Companies’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$0	Buy	+18	New	–	﹤0.01%	992

Other funds holding SRNE

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Financial Gravity Companies's SRNE Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in Sorrento Therapeutics, Inc. (SRNE) in Q2 2025: 18 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #992 among its holdings.

2 funds tracked by Wall St. Rank hold SRNE as of Q2 2025.

Financial Gravity Companies held 18 shares of Sorrento Therapeutics, Inc. worth $0 as of Q2 2025.
Sorrento Therapeutics, Inc. was a new Financial Gravity Companies position in Q2 2025.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2025, its #992 holding.
2 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.